Recovery of complete antiemetic response with APF530 during treatment with moderately (MEC) and highly (HEC) emetogenic chemotherapy regimens in patients who failed palonosetron.
Roberto Arevalo-Araujo
No relevant relationships to disclose
Erin O'Boyle
Employment or Leadership Position - A.P. Pharma
Stock Ownership - A.P. Pharma
William Cooper
Employment or Leadership Position - Beardsworth Consulting Group
Paul Alexander Robertson
No relevant relationships to disclose